ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ELX El Oro Ltd

65.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
El Oro Ltd LSE:ELX London Ordinary Share GG00B77Q7194 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 65.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

El Oro Ltd Result of Scheme of Reconstruction (1666E)

02/07/2019 9:00am

UK Regulatory


El Oro (LSE:ELX)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more El Oro Charts.

TIDMELX

RNS Number : 1666E

El Oro Ltd

02 July 2019

2 July 2019

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA OR THE REPUBLIC OF SOUTH AFRICA

El Oro Ltd

Result of Scheme of Reconstruction

In relation to the recommended proposals for the voluntary winding-up and reconstruction of El Oro Ltd (the "Company") as set out in the circular published by the Company dated 24 May 2019 (the "Circular"), the Company announces the following.

Further to the approval of the resolutions to put the Company into voluntary liquidation which were proposed and duly passed on 20 June 2019, Nick Vermeulen and Christiaan Van Den Berg, both of PricewaterhouseCoopers CI LLP of Royal Bank Place, 1 Glategny Esplanade, St Peter Port, Guernsey, GY1 4ND have been appointed as liquidators.

Application has been made to the TISEA and the London Stock Exchange for the listing of the Reclassified Shares on the premium segment of the Official List and for trading on the SETSqx trading platform respectively to be cancelled at 7.00 a.m. on 22 July 2019.

Residual Value

On the Calculation Date the unaudited net asset value of the Company was GBP46,215,013.27 (calculated on a bid basis and providing for the estimated expenses of the winding up of the Company of GBP440,000, the value of the Illiquid Assets of GBP1,142,692.69 which will be retained in the Liquidation Fund and a retention for the Liquidation Fund of GBP500,000). On this basis, the Residual Value of an El Oro Share as at Thursday 27 June 2019 was GBP0.70959893 per Share.

Accordingly, and based on the elections and deemed elections, the aggregate value attributable to each of the Rollover Funds and to the Cash Option are as follows:

 
JPMorgan Elect Managed Growth Shares   GBP5,888,812.67 
JPMorgan Elect Managed Income Shares  GBP19,480,689.52 
                                      ---------------- 
JPMorgan Elect Managed Cash Shares       GBP805,188.04 
                                      ---------------- 
Cash Option                           GBP18,397,142.28 
                                      ---------------- 
 

Issue Prices

The JPMorgan Elect Issue Prices calculated as at 27 June 2019 were as follows:

 
JPMorgan Elect Managed Growth Shares (p)   870.92 
JPMorgan Elect Managed Income Shares (p)   110.69 
                                           ------ 
JPMorgan Elect Managed Cash Shares (p)     104.03 
                                           ------ 
 

Settlement of Elections made by Shareholders will be as set out in the Circular with cheques expected to be despatched and CREST payments made to Shareholders in respect of the Cash Option on or as soon as practicable after 3 July 2019 and share certificates for JPMorgan Elect Securities issued under the Scheme expected to be despatched in the week commencing 15 July 2019.

Distributions from the Liquidation Fund

To the extent that any part of the Liquidation Fund is not required to meet the Company's liabilities or the liabilities of the UK Subsidiaries, including the net proceeds of sale of any of the Illiquid Assets, the balance remaining in the hands of the Liquidators will be paid as one or more liquidation distributions to Shareholders who are on the Company's register of members as at the close of business on the Scheme Effective Date on a pari passu basis pro rata to their respective holdings of Shares, provided that if any such amount otherwise payable to a Shareholder is less than GBP5.00, it will not be paid to such Shareholder but will be transferred by the Liquidators to a charity, Cancer Research UK (Registered Charity Number 1089464) (the Nominated Charity).

Shareholders will receive communication(s) from the Liquidators in due course.

Notes

Terms used and not defined in this announcement have the meanings given in the Circular unless the context otherwise requires.

For further information:

Liquidator:

Natalie Boes

natalie.boes@pwc.com

07911 163663

Nick Vermeulen

nick.vermeulen@pwc.com

01481 752000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCLIFVDDIIFIIA

(END) Dow Jones Newswires

July 02, 2019 04:00 ET (08:00 GMT)

1 Year El Oro Chart

1 Year El Oro Chart

1 Month El Oro Chart

1 Month El Oro Chart

Your Recent History

Delayed Upgrade Clock